Related Experiment Video

Updated: Aug 29, 2025

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

512

The updated pre-test probability model of the 2019 ESC guidelines improves prediction of obstructive coronary artery

Pedro M Lopes1, Francisco Albuquerque1, Pedro Freitas1

  • 1Department of Cardiology, Hospital Santa Cruz, Centro Hospitalar Lisboa Ocidental, Carnaxide, Lisbon, Portugal.

Revista Portuguesa De Cardiologia : Orgao Oficial Da Sociedade Portuguesa De Cardiologia = Portuguese Journal of Cardiology : an Official Journal of the Portuguese Society of Cardiology
|September 5, 2022
PubMed

Insights

The 2019 ESC guidelines offer a more accurate method for estimating pre-test probability (PTP) of obstructive coronary artery disease (CAD). This updated PTP model improves disease prediction and guides non-invasive testing selection compared to the 2013 model.

Area of Science:

  • Cardiology
  • Diagnostic Imaging
  • Medical Guidelines

Background:

  • Chronic coronary syndromes (CCS) management guidelines have evolved.
  • Accurate pre-test probability (PTP) estimation is crucial for diagnosing obstructive coronary artery disease (CAD).
  • The 2019 European Society of Cardiology (ESC) guidelines introduced an updated PTP prediction model for obstructive CAD.

Purpose of the Study:

  • To compare the performance of the 2019 ESC PTP method against the 2013 prediction model.
  • To evaluate PTP estimation in patients with stable chest pain undergoing coronary computed tomography angiography (CCTA).
  • To assess the impact of the updated PTP model on downstream diagnostic pathways.

Main Methods:

  • A single-center cross-sectional study included 320 consecutive patients suspected of CAD.
  • Coronary computed tomography angiography (CCTA) was used to assess obstructive CAD (≥50% luminal stenosis).
  • Calibration, discrimination, and diagnostic pathway impact of both 2013 and 2019 PTP models were evaluated.

Main Results:

  • The 2013 model significantly overestimated obstructive CAD likelihood (130% overestimation).
  • The 2019 method demonstrated good calibration with minimal underestimation (6.5%).
  • Both models had similar discriminative power (C-statistics 0.73 vs. 0.74), but the 2019 method showed significant net reclassification improvement (0.10, p=0.001).

Conclusions:

  • The 2019 PTP prediction model offers a more accurate estimation of obstructive CAD likelihood than the 2013 model.
  • Adoption of the updated 2019 score may enhance disease prediction accuracy.
  • The new PTP model has the potential to optimize the selection of non-invasive diagnostic tests for suspected CAD.
Abstract

Keywords:
Angiotomografia das artérias coronáriasCoronary artery diseaseCoronary computed tomography angiographyDoença arterial coronáriaPretest probabilityProbabilidade pré-teste

More Related Videos

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.1K
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

5.2K

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
108
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
31
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
21
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
47
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
26
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
24